Healthcare

According to a market report by Lucintel, the future of the biologics safety testing market looks promising with opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing. The global biologics safety testing market is expected to reach an estimated $8.2 billion by 2028 with a CAGR of 12.8% from 2023 to 2028. The major drivers for this market are increasing pharmaceutical and biotechnology industry, rising concerns over cell culture contamination, and growing R&D investment in life science segment.



In this market, endotoxin test, sterility test, mycoplasma tests, bioburden tests, residual host-cell proteins & DNA detection tests, and virus safety test are the major type segments. Lucintel forecasts that residual host-cell proteins & DNA detection tests are expected to witness the highest growth over the forecast period as it enables the biopharmaceutical manufacturers to demonstrate the safety and purity of their products before the regulatory authorities by testing for residual host cell proteins and DNA.



Within this market, vaccine development and manufacturing is expected to witness the highest growth over the forecast period due to increasing number of infectious diseases and growing necessity of biologics safety testing for quality assurance.



North America is expected to remain the largest region over the forecast period due to increasing investment in R&D in the biopharmaceutical industry, growing number of biological products and novel drugs, and rising awareness among population towards product safety.

Charles River Laboratories, Lonza, Thermo Fisher Scientific, Merck KGaA, and F. Hoffmann-La Roche, are the major suppliers in the global biologics safety testing market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global biologics safety testing market by type, product & services, application, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Biologics Safety Testing Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global biologics safety testing market by type, product & services, application, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the biologics safety testing market by type (endotoxin test, sterility test, mycoplasma tests, bioburden tests, residual host-cell proteins & DNA detection tests, virus safety test, and others), product & service (consumables, instrument, and services), application (vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, blood and blood product development and manufacturing, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?